New Products and Promotions for Mimix Reference Standards
Discover our new products and the latest promotions and special offers for Mimix™ reference standards. Bookmark this page and check back often, as it is updated regularly.
Our Mimix reference standards are cell line-derived to bring patient-like performance to your cancer workflows. We are continuously innovating and expanding our Mimix range to bring you new controls, whether it's cancer-specific or pan-cancer standards, new allelic frequences, or new formats such as FFPE, gDNA, cfDNA and fcDNA.
Drawing on over 15 years of developing oncology controls, quality is a critical part of our development cycle, with products manufactured under an ISO-certified quality management system and rigorously QC tested to support batch-to-batch consistency.
Latest Mimix Reference Standards
Mimix™ Geni™ Onco Mix 1 DNA/RNA FFPE Reference Standard, IVD
Seven mutations with clinical relevance in oncology testing, selected by industry experts, have been engineered into a Genome-in-a-Bottle Consortium cell line. The result is a highly characterized somatic cancer reference standard that you can trust to verify and monitor your oncology detection assays and workflow. This industry-first pan-cancer dual DNA/RNA reference material has been developed in collaboration with the Medical Device Innovation Consortium (MDIC). A negative control is also available (HD876-IVD)
For in vitro diagnostic use. This product is only available where licensed in accordance with law. Please contact your local representative for availability.
Learn more
Mimix™ OncoMatch™ Lung Cancer Positive and Negative FFPE reference standards
Detect lung cancer mutations with greater confidence. These reference standards are quality, cancer-specific controls to support the precise identification of somatic variants. Together, they serve as a source for testing paired sample sets to evaluate the comprehensive performance of molecular biology assays.
For research use only. Not for use in diagnostic procedures.
Positive control Negative control
Mimix™ Geni™ Onco Mix 1 DNA/RNA FFPE Reference Standard
An industry-first pan-cancer dual DNA/RNA reference material developed in collaboration with the Medical Device Innovation Consortium (MDIC). Seven cancer mutations with clinical relevance, as selected by industry experts, have been engineered into a Genome-in-a-Bottle Consortium cell line, providing a highly characterized somatic cancer reference standard you can trust to verify and monitor your oncology detection assays and workflow.
For research use only. Not for use in diagnostic procedures.
Learn more
Mimix™ Quantitative Multiplex FFPE Reference Standard IVD
A cell line-derived pan-cancer reference standard, featuring 11 variants across 6 key cancer genes. These variants range from 0.8-24.5% allelic frequency (AF), to aid in the limit of detection (LOD) determination of your assay.
For In Vitro Diagnostic Use. This product is only available where licensed in accordance with law. Please contact your local representative for availability.
Learn more
Mimix™ OncoSpan™ FFPE Reference Standard IVD
This reference standard is a commutable control material consisting of a blend of human cancer cell lines that have been fixed in formalin and embedded in paraffin blocks, and feature 386 variants across 152 essential cancer genes.
For In Vitro Diagnostic Use. This product is only available where licensed in accordance with law. Please contact your local representative for availability.
Learn more
Mimix™ OncoSpan™ gDNA Reference Standard IVD
This reference standard is a commutable genomic DNA control material, consisting of extracted genomic DNA from a blend of human cancer cell lines and containing 386 variants across 152 key cancer genes.
For In Vitro Diagnostic Use. This product is only available where licensed in accordance with law. Please contact your local representative for availability.
Learn more
Mimix™ Myeloid Cancer Panel gDNA Reference Standard IVD
This standard is a versatile genomic DNA control material, consisting of extracted genomic DNA from a blend of human cancer cell lines and includes 22 variants across 19 genes pertinent to myeloid cancer.
For In Vitro Diagnostic Use. This product is only available where licensed in accordance with law. Please contact your local representative for availability.
Learn more
Mimix™ OncoPure Colorectal Cancer, FFPE reference standard
The Mimix OncoPure Colorectal Cancer FFPE reference standard is a cancer-specific quality control for evaluating the performance of molecular biology assays. It offers a highly accurate representation of patient samples, and is derived from a single CRC tumor cell line without any modifications or engineering.
For research use only. Not for use in diagnostic procedures.
Learn more
Mimix Quantitative Multiplex Moderate FFPE Reference Standard
Developed based on customer feedback, the Mimix Quantitative Multiplex Moderate FFPE reference standard is a biologically-relevant quality control material for assessing the performance of molecular biology assays that detect somatic mutation. It has more degraded DNA than the standard Quantitative Multiplex FFPE product (HD200) to even more closely mimic patient samples in research set-ups.
For research use only. Not for use in diagnostic procedures.
Learn more
Mimix Genomic DNA male – Male reference standard
This Mimix gDNA reference standard is a biologically-relevant quality control material which can be used to assess the performance and consistency of various molecular biology assays such as qPCR, ddPCR, Sanger sequencing and NGS.
For research use only. Not for use in diagnostic procedures.
Learn moreMimix Promotions and Special Offers
Carousel items